ES2986469T3 - Tratamiento y prevención de glioblastoma - Google Patents

Tratamiento y prevención de glioblastoma Download PDF

Info

Publication number
ES2986469T3
ES2986469T3 ES19829028T ES19829028T ES2986469T3 ES 2986469 T3 ES2986469 T3 ES 2986469T3 ES 19829028 T ES19829028 T ES 19829028T ES 19829028 T ES19829028 T ES 19829028T ES 2986469 T3 ES2986469 T3 ES 2986469T3
Authority
ES
Spain
Prior art keywords
selective
adrenergic receptor
day
receptor antagonist
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19829028T
Other languages
English (en)
Spanish (es)
Inventor
Gonzalez-Carvajal José María Sanchez-Puelles
Cubells Luisa María Botella
Sanchez Tania Aguado
Martinez Angel Cuesta
Diaz Virginia Albinana
Gomez-De Las Heras Karina Villar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alianza Espanola De Familias De Von Hippel Lindau Vhl
Consorcio Centro De Investig Biomedica En Redm P
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Alianza Espanola De Familias De Von Hippel Lindau Vhl
Consorcio Centro De Investig Biomedica En Redm P
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alianza Espanola De Familias De Von Hippel Lindau Vhl, Consorcio Centro De Investig Biomedica En Redm P, Consejo Superior de Investigaciones Cientificas CSIC filed Critical Alianza Espanola De Familias De Von Hippel Lindau Vhl
Application granted granted Critical
Publication of ES2986469T3 publication Critical patent/ES2986469T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES19829028T 2018-12-12 2019-12-12 Tratamiento y prevención de glioblastoma Active ES2986469T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382917.5A EP3666266A1 (en) 2018-12-12 2018-12-12 Treatment and prevention of glioblastoma
PCT/EP2019/084822 WO2020120656A1 (en) 2018-12-12 2019-12-12 Treatment and prevention of glioblastoma

Publications (1)

Publication Number Publication Date
ES2986469T3 true ES2986469T3 (es) 2024-11-11

Family

ID=64746483

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19829028T Active ES2986469T3 (es) 2018-12-12 2019-12-12 Tratamiento y prevención de glioblastoma

Country Status (7)

Country Link
US (1) US20220008362A1 (https=)
EP (2) EP3666266A1 (https=)
JP (1) JP7746157B2 (https=)
CN (1) CN113365619A (https=)
CA (1) CA3122640A1 (https=)
ES (1) ES2986469T3 (https=)
WO (1) WO2020120656A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3048032A1 (es) * 2025-05-27 2025-12-05 Univ Madrid Complutense N-(4-Ariloxi-3-hidroxibutan-2-il)alcanamidas con actividad antagonista adrenérgica beta-2 selectiva

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015121500A1 (en) * 2014-02-17 2015-08-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions for use in the treatment of ventilator-induced diaphragmatic dysfunction

Also Published As

Publication number Publication date
EP3893861B1 (en) 2024-08-07
CN113365619A (zh) 2021-09-07
JP2022517517A (ja) 2022-03-09
EP3893861C0 (en) 2024-08-07
JP7746157B2 (ja) 2025-09-30
US20220008362A1 (en) 2022-01-13
CA3122640A1 (en) 2020-06-18
WO2020120656A1 (en) 2020-06-18
EP3666266A1 (en) 2020-06-17
EP3893861A1 (en) 2021-10-20

Similar Documents

Publication Publication Date Title
JP6553092B2 (ja) 脳がんを治療するための化合物
JP6509386B2 (ja) ｍＴＯＲ経路関連疾患を治療するための化合物
ES2713699T3 (es) 17alfa,21-Diésteres de cortexolona para el uso en el tratamiento de tumores
ES2791539T3 (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresión de DUX4
ES2966954T3 (es) Tinostamustina para usar en el tratamiento de la leucemia prolinfocítica de linfocitos T
JP7166021B2 (ja) 癌の処置のためのドーパミンβ－ヒドロキシラーゼ（ＤＢＨ）阻害剤およびセロトニン受容体（５－ＨＴ）アンタゴニストの使用
US20160220527A1 (en) Kinase inhibitors for the treatment of cancer
ES2986469T3 (es) Tratamiento y prevención de glioblastoma
CA2890108C (en) Method for treating prostate cancer
ES2870909T3 (es) Usos de un compuesto en la preparación de fármacos para el tratamiento del glioma cerebral
EP4013417A1 (en) Methods and compositions for treating vascular malformations
US20210023107A1 (en) USE OF 6-THIO-dG TO TREAT THERAPY-RESISTANT TELOMERASEPOSITIVE PEDIATRIC BRAIN TUMORS
TWI594982B (zh) 低細胞毒性血管阻斷劑
JP2017512768A (ja) Ｅｒｇ発癌遺伝子陽性癌のための新規阻害剤
US20220339145A1 (en) Compositions and Methods for Treating Cancer
Sánchez-Puelles et al. Treatment and prevention of glioblastoma
US20240358678A1 (en) Methods and compositions for enhancing chemotherapeutic drug uptake into brain tumors
US11730707B2 (en) Compounds for treating von Hippel-Lindau disease
CA3072389C (en) Selective beta2-adrenergic receptor antagonist for treating von hippel-lindau disease
HK1205500B (en) Kinase inhibitors for the treatment of cancer